Cara Therapeutics, Inc. (CARA): Price and Financial Metrics
CARA Price/Volume Stats
| Current price | $15.96 | 52-week high | $16.56 |
| Prev. close | $5.55 | 52-week low | $2.71 |
| Day low | $15.84 | Volume | 79,033 |
| Day high | $16.56 | Avg. volume | 33,159 |
| 50-day MA | $5.06 | Dividend yield | N/A |
| 200-day MA | $4.21 | Market Cap | 73.00M |
CARA Stock Price Chart Interactive Chart >
Cara Therapeutics, Inc. (CARA) Company Bio
Cara Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors. The company was founded in 2004 and is based in Shelton, Connecticut.
CARA Price Returns
| 1-mo | N/A |
| 3-mo | 8.57% |
| 6-mo | 12.00% |
| 1-year | 55.01% |
| 3-year | -95.39% |
| 5-year | -97.49% |
| YTD | -13.07% |
| 2024 | -31.36% |
| 2023 | -93.08% |
| 2022 | -11.82% |
| 2021 | -19.50% |
| 2020 | -6.08% |
Continue Researching CARA
Want to do more research on Cara Therapeutics Inc's stock and its price? Try the links below:Cara Therapeutics Inc (CARA) Stock Price | Nasdaq
Cara Therapeutics Inc (CARA) Stock Quote, History and News - Yahoo Finance
Cara Therapeutics Inc (CARA) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...